androstenedione has been researched along with nafarelin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, RB; Burstein, S; Ehrmann, DA; Rosenfield, RL | 1 |
| Nilsson, CG; Roine, R; Välimäki, M; Ylikorkala, O | 1 |
| Andreyko, JL; Blumenfeld, Z; Hricak, H; Jaffe, RB; Marshall, LA; Monroe, SE | 1 |
| Barnes, RB; Ehrmann, DA; Rosenfield, RL | 1 |
| Ghai, K; Rosenfield, RL | 1 |
| Barnes, RB; Levrant, SG; Rosenfield, RL | 1 |
| Demant, T; Halser, B; Strowitzki, T | 1 |
2 trial(s) available for androstenedione and nafarelin
| Article | Year |
|---|---|
Comparison between the effects of nafarelin and danazol on serum lipids and lipoproteins in patients with endometriosis.
Topics: Adult; Androstenedione; Cholesterol; Clinical Trials as Topic; Danazol; Double-Blind Method; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Lipids; Lipoproteins; Nafarelin; Pregnadienes; Random Allocation; Testosterone; Triglycerides | 1989 |
A pilot study of the human chorionic gonadotrophin test for ovarian hyperandrogenism.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androstenedione; Chorionic Gonadotropin; Female; Hormones; Humans; Hyperandrogenism; Kinetics; Male; Nafarelin; Pilot Projects; Testosterone | 1997 |
5 other study(ies) available for androstenedione and nafarelin
| Article | Year |
|---|---|
Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome.
Topics: 3-Hydroxysteroid Dehydrogenases; Adolescent; Adult; Androstenedione; Dexamethasone; Estrogens; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hydroxyprogesterones; Luteinizing Hormone; Male; Nafarelin; Ovary; Pituitary Gland, Anterior; Polycystic Ovary Syndrome; Stimulation, Chemical | 1989 |
Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging.
Topics: Adult; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Drug Evaluation; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Luteinizing Hormone; Magnetic Resonance Imaging; Nafarelin; Testosterone; Time Factors; Uterine Neoplasms | 1988 |
Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androstenedione; Dexamethasone; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydroxyprogesterones; Hyperandrogenism; Luteinizing Hormone; Nafarelin; Ovarian Diseases; Testosterone | 1994 |
Maturation of the normal pituitary-testicular axis, as assessed by gonadotropin-releasing hormone agonist challenge.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Analysis of Variance; Androstenedione; Child; Dehydroepiandrosterone; Estradiol; Follicle Stimulating Hormone; Humans; Hydroxyprogesterones; Luteinizing Hormone; Male; Nafarelin; Pituitary Gland; Progesterone; Puberty; Reference Values; Testis; Testosterone | 1994 |
Body fat distribution, insulin sensitivity, ovarian dysfunction and serum lipoproteins in patients with polycystic ovary syndrome.
Topics: 17-alpha-Hydroxyprogesterone; Adipose Tissue; Adrenal Glands; Adult; Androstenedione; Body Composition; Body Constitution; Body Mass Index; Body Weight; Cholesterol, HDL; Fasting; Female; Humans; Insulin; Insulin Resistance; Lipoproteins; Lipoproteins, LDL; Nafarelin; Ovary; Polycystic Ovary Syndrome; Testosterone; Triglycerides | 2002 |